Gallo JM - Search Results

1

In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.

Devineni D, Klein-Szanto A, Gallo JM. Devineni D, et al. Among authors: gallo jm. Cancer Chemother Pharmacol. 1996;38(6):499-507. doi: 10.1007/s002800050518. Cancer Chemother Pharmacol. 1996. PMID: 8823490

2

Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.

Devineni D, Klein-Szanto A, Gallo JM. Devineni D, et al. Among authors: gallo jm. Cancer Res. 1996 May 1;56(9):1983-7. Cancer Res. 1996. PMID: 8616836

3

Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors.

Devineni D, Klein-Szanto A, Gallo JM. Devineni D, et al. Among authors: gallo jm. J Neurooncol. 1995;24(2):143-52. doi: 10.1007/BF01078484. J Neurooncol. 1995. PMID: 7562001

4

Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems.

Devineni D, Blanton CD, Gallo JM. Devineni D, et al. Among authors: gallo jm. Bioconjug Chem. 1995 Mar-Apr;6(2):203-10. doi: 10.1021/bc00032a008. Bioconjug Chem. 1995. PMID: 7599263

5

Zalcitabine. Clinical pharmacokinetics and efficacy.

Devineni D, Gallo JM. Devineni D, et al. Among authors: gallo jm. Clin Pharmacokinet. 1995 May;28(5):351-60. doi: 10.2165/00003088-199528050-00002. Clin Pharmacokinet. 1995. PMID: 7614775 Review.

6

Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.

Ma J, Fei ZL, Klein-Szanto A, Gallo JM. Ma J, et al. Among authors: gallo jm. Clin Exp Metastasis. 1998 Aug;16(6):559-68. doi: 10.1023/a:1006598419541. Clin Exp Metastasis. 1998. PMID: 9872603

7

Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

Belinsky MG, Guo P, Lee K, Zhou F, Kotova E, Grinberg A, Westphal H, Shchaveleva I, Klein-Szanto A, Gallo JM, Kruh GD. Belinsky MG, et al. Among authors: gallo jm. Cancer Res. 2007 Jan 1;67(1):262-8. doi: 10.1158/0008-5472.CAN-06-2680. Cancer Res. 2007. PMID: 17210706

8

Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model.

Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Guo P, et al. Among authors: gallo jm. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76. doi: 10.1007/s002800100284. Cancer Chemother Pharmacol. 2001. PMID: 11561783

9

Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.

Shen M, Schilder RJ, Obasaju C, Gallo JM. Shen M, et al. Among authors: gallo jm. Cancer Chemother Pharmacol. 2002 Sep;50(3):243-50. doi: 10.1007/s00280-002-0490-y. Epub 2002 Jul 16. Cancer Chemother Pharmacol. 2002. PMID: 12203107

10

Application of microdialysis to characterize drug disposition in tumors.

Chu J, Gallo JM. Chu J, et al. Among authors: gallo jm. Adv Drug Deliv Rev. 2000 Dec 15;45(2-3):243-53. doi: 10.1016/s0169-409x(00)00115-0. Adv Drug Deliv Rev. 2000. PMID: 11108977 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters